Compare BLTE & GTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLTE | GTES |
|---|---|---|
| Founded | 2018 | 1911 |
| Country | United States | United States |
| Employees | N/A | 13000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 6.2B |
| IPO Year | 2021 | 2017 |
| Metric | BLTE | GTES |
|---|---|---|
| Price | $137.18 | $24.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $198.00 | $28.56 |
| AVG Volume (30 Days) | 104.2K | ★ 2.0M |
| Earning Date | 05-08-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.73 |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $5.83 |
| Revenue Next Year | $492.11 | $3.95 |
| P/E Ratio | ★ N/A | $106.65 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $56.68 | $20.59 |
| 52 Week High | $200.00 | $28.47 |
| Indicator | BLTE | GTES |
|---|---|---|
| Relative Strength Index (RSI) | 31.51 | 47.74 |
| Support Level | $103.94 | $23.84 |
| Resistance Level | $172.02 | $26.29 |
| Average True Range (ATR) | 7.11 | 0.79 |
| MACD | -1.16 | -0.19 |
| Stochastic Oscillator | 7.06 | 40.00 |
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment. Company operates in USA, United Kingdom, Luxembourg, EMEA, with majority revenue from USA.